GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cizzle Biotechnology Holdings PLC (LSE:CIZ) » Definitions » 5-Year Dividend Growth Rate

Cizzle Biotechnology Holdings (LSE:CIZ) 5-Year Dividend Growth Rate : 0.00% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Cizzle Biotechnology Holdings 5-Year Dividend Growth Rate?

Cizzle Biotechnology Holdings's Dividends per Share for the six months ended in Jun. 2024 was £0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Cizzle Biotechnology Holdings's Dividend Payout Ratio for the six months ended in Jun. 2024 was 0.00. As of today, Cizzle Biotechnology Holdings's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Cizzle Biotechnology Holdings's 5-Year Dividend Growth Rate

For the Biotechnology subindustry, Cizzle Biotechnology Holdings's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cizzle Biotechnology Holdings's 5-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cizzle Biotechnology Holdings's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Cizzle Biotechnology Holdings's 5-Year Dividend Growth Rate falls into.



Cizzle Biotechnology Holdings 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Cizzle Biotechnology Holdings  (LSE:CIZ) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Cizzle Biotechnology Holdings's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2024 )/ EPS without NRI (Q: Jun. 2024 )
=0/ -0.001
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cizzle Biotechnology Holdings 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Cizzle Biotechnology Holdings's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Cizzle Biotechnology Holdings Business Description

Traded in Other Exchanges
N/A
Address
C/o SGH Secretaries Limited, 60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Cizzle Biotechnology Holdings PLC is in the early stages of developing a blood test for the early detection of a majority of the different forms of lung cancer. Its proof-of-concept prototype test is based on the ability to detect a stable plasma biomarker, a variant of C1Z1 known as CIZ1B. C1Z1 is a naturally occurring cell nuclear protein involved in DNA replication, and the targeted C1Z1B variant is correlated with early stage lung cancer.

Cizzle Biotechnology Holdings Headlines